Literature DB >> 15351386

Cocaine pharmacology and current pharmacotherapies for its abuse.

M Rocío A Carrera1, Michael M Meijler, Kim D Janda.   

Abstract

Cocaine abuse continues to be prevalent and effective therapies for cocaine craving and addiction remain elusive. In the last decade immunopharmacotherapy has been proposed as a promising means to alleviate this illness. By using the organism's natural immune response, an anti-cocaine vaccine promotes the production of cocaine-specific antibodies that sequester the drug before their passage into the brain, where it exerts its reinforcing and thus addictive effects. A series of studies demonstrating the cocaine-blocking properties of various immunogenic conjugates will be reviewed in the context of the neuropsychopharmacological profile of the drug.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351386     DOI: 10.1016/j.bmc.2004.06.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

1.  An antidote for acute cocaine toxicity.

Authors:  Jennifer B Treweek; Kim D Janda
Journal:  Mol Pharm       Date:  2012-03-20       Impact factor: 4.939

2.  Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design.

Authors:  Xiaoqing Cai; Timothy Whitfield; Mark S Hixon; Yanabel Grant; George F Koob; Kim D Janda
Journal:  J Med Chem       Date:  2013-04-29       Impact factor: 7.446

3.  Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.

Authors:  Daniela Rüedi-Bettschen; Sherri L Wood; Melinda G Gunnell; C Michael West; Rama R Pidaparthi; F Ivy Carroll; Bruce E Blough; S Michael Owens
Journal:  Vaccine       Date:  2013-07-29       Impact factor: 3.641

4.  [Cocaine abuse in Vienna and European cities--a multi-center study].

Authors:  Andjela Bäwert; Nicole Primus; Reinhold Jagsch; Harald Eder; Margarete Zanki; Kenneth Thau; Gabriele Fischer
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

Review 5.  Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse.

Authors:  F Ivy Carroll; James L Howard; Leonard L Howell; Barbara S Fox; Michael J Kuhar
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

6.  Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.

Authors:  Chunyang Jin; Hernán A Navarro; F Ivy Carroll
Journal:  Bioorg Med Chem       Date:  2008-04-10       Impact factor: 3.641

7.  Modulating cocaine vaccine potency through hapten fluorination.

Authors:  Xiaoqing Cai; Kyoji Tsuchikama; Kim D Janda
Journal:  J Am Chem Soc       Date:  2013-02-14       Impact factor: 15.419

8.  Probing the effects of hapten stability on cocaine vaccine immunogenicity.

Authors:  Xiaoqing Cai; Timothy Whitfield; Amira Y Moreno; Yanabel Grant; Mark S Hixon; George F Koob; Kim D Janda
Journal:  Mol Pharm       Date:  2013-10-04       Impact factor: 4.939

9.  Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.

Authors:  Chunyang Jin; Hernán A Navarro; Kevin Page; F Ivy Carroll
Journal:  Bioorg Med Chem       Date:  2008-06-02       Impact factor: 3.641

10.  Cocaine Reduces Ciliary Beat Frequency of Human Nasal Epithelial Cells.

Authors:  Alexander Nastev; J Ulrich Sommer; Wieland Behr; Boris A Stuck; C Emika Mueller; Angela Schell; Benedikt Kramer; Daniel Haeussler; Karl Hoermann; Richard Birk
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.